Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review

Documenti analoghi

• Utilization and cost of non‐insulin glucose‐lowering drugs in Australia from 2013 to 2023
  di: Peter S. Hamblin, et al.
  Pubblicazione: (2024)
• Unveiling glycaemic variability patterns linked to the triglyceride‐glucose index in type 2 diabetes: Insights from continuous glucose monitoring
  di: Yunxiao Wu, et al.
  Pubblicazione: (2026)
• Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring
  di: Howard Wolpert, et al.
  Pubblicazione: (2025)
• Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial
  di: Rui Sun, et al.
  Pubblicazione: (2025)
• Long‐term effects of continuous glucose monitoring on glycaemic control: Real‐world evidence in a general adult population with type 1 diabetes in Norway
  di: Bjørn O. Åsvold, et al.
  Pubblicazione: (2025)